Apex Science (Taiwan) Performance
| 3052 Stock | TWD 11.75 0.15 1.26% |
Apex Science has a performance score of 10 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Apex Science's returns are expected to increase less than the market. However, during the bear market, the loss of holding Apex Science is expected to be smaller as well. Apex Science Engineering right now shows a risk of 0.85%. Please confirm Apex Science Engineering market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to decide if Apex Science Engineering will be following its price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Apex Science Engineering are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Apex Science may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
| Begin Period Cash Flow | 209.2 M | |
| Total Cashflows From Investing Activities | -566 M |
Apex |
Apex Science Relative Risk vs. Return Landscape
If you would invest 1,100 in Apex Science Engineering on October 19, 2025 and sell it today you would earn a total of 75.00 from holding Apex Science Engineering or generate 6.82% return on investment over 90 days. Apex Science Engineering is generating 0.11% of daily returns and assumes 0.8522% volatility on return distribution over the 90 days horizon. Simply put, 7% of stocks are less volatile than Apex, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Apex Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apex Science's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Apex Science Engineering, and traders can use it to determine the average amount a Apex Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1291
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | 3052 | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.85 actual daily | 7 93% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Apex Science is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apex Science by adding it to a well-diversified portfolio.
Apex Science Fundamentals Growth
Apex Stock prices reflect investors' perceptions of the future prospects and financial health of Apex Science, and Apex Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Apex Stock performance.
| Return On Equity | 0.0563 | |||
| Return On Asset | 0.0083 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 5.81 B | |||
| Shares Outstanding | 196.06 M | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 0.66 X | |||
| Price To Sales | 0.73 X | |||
| Revenue | 3.61 B | |||
| EBITDA | 170.85 M | |||
| Cash And Equivalents | 171.92 M | |||
| Cash Per Share | 0.86 X | |||
| Total Debt | 504.65 M | |||
| Debt To Equity | 201.60 % | |||
| Book Value Per Share | 15.53 X | |||
| Cash Flow From Operations | 544.89 M | |||
| Earnings Per Share | 0.87 X | |||
| Total Asset | 8.17 B | |||
| Retained Earnings | 576 M | |||
| Current Asset | 8.13 B | |||
| Current Liabilities | 5.66 B | |||
About Apex Science Performance
Evaluating Apex Science's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Apex Science has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Apex Science has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Apex Science Engineering Corp. operates as an engineering and construction manufacturing and service company worldwide. Apex Science Engineering Corp. was founded in 1976 and is headquartered in New Taipei City, Taiwan. APEX SCIENCE operates under Engineering Construction classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Apex Science Engineering performance evaluation
Checking the ongoing alerts about Apex Science for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Apex Science Engineering help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Apex Science has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 46.0% of the company shares are owned by insiders or employees |
- Analyzing Apex Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Apex Science's stock is overvalued or undervalued compared to its peers.
- Examining Apex Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Apex Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Apex Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Apex Science's stock. These opinions can provide insight into Apex Science's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Apex Stock Analysis
When running Apex Science's price analysis, check to measure Apex Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Science is operating at the current time. Most of Apex Science's value examination focuses on studying past and present price action to predict the probability of Apex Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Science's price. Additionally, you may evaluate how the addition of Apex Science to your portfolios can decrease your overall portfolio volatility.